ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,082, issued on Sept. 1, was assigned to BIOSION INC. (Nanjing, China). "Monoclonal antibodies which bind PD-1, encoding nucleotides thereof... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,084, issued on Sept. 1, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "4-1BBL trimer-containing antigen binding molecules" w... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,085, issued on Sept. 1, was assigned to NANJING SANHOME PHARMACEUTICAL Co. LTD. (Nanjing, China). "Anti-TIGIT antibody and double antibody ... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,086, issued on Sept. 1, was assigned to Nanjing Leads Biolabs Co. Ltd. (Nanjing, China). "Antibodies binding 4-1BB and uses thereof" was in... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,087, issued on Sept. 1, was assigned to Momenta Pharmaceuticals Inc. (Titusville, N.J.). "Anti-FcRn antibodies and methods for treating mya... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,088, issued on Sept. 1, was assigned to Agency for Science, Technology and Research (Singapore). "Antigen binding molecules and methods the... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,089, issued on Sept. 1, was assigned to The Brigham and Women's Hospital Inc. (Boston). "KLRB1 binding agents and methods of use thereof" w... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,090, issued on Sept. 1, was assigned to The Brigham and Women's Hospital Inc. (Boston). "KLRB1 binding agents and methods of use thereof" w... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,091, issued on Sept. 1, was assigned to DIZAL (JIANGSU) PHARMACEUTICAL Co. LTD. (Shanghai). "Anti-FGFR2B antibodies" was invented by Mei Wa... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,092, issued on Sept. 1, was assigned to KAOHSIUNG MEDICAL UNIVERSITY (Kaohsiung City, Taiwan). "Anti-CXCR2 antibodies and uses thereof" was... Read More